LAUSR

Lipid-based nanoparticles have recently shown great promise, establishing themselves as the gold standard in delivering novel RNA therapeutics. However, research on the effects of storage on their efficacy, safety and stability is still lacking. Here, we explore the impact of storage temperature on two types of lipid-based nanocarriers, lipid nanoparticles (LNPs) and receptor-targeted nanoparticles (RTNs), loaded with either DNA or mRNA, and investigate the effects of different cryoprotectants on the stability and efficacy of the formulations. The medium-term stability of the nanoparticles was evaluated by monitoring their physicochemical characteristics, entrapment efficiency, and transfection efficiency, every 2 weeks over one month. We demonstrate that the use of cryoprotectants with nanocomplexes protects them against loss of function and degradation in all storage conditions. Moreover, we show that the addition of sucrose enables all nanoparticles to remain stable and maintain their efficacy for up to a month when stored at -80°C, regardless of cargo or type of nanoparticle. DNA-loaded nanoparticles also remained stable in a wider variety of storage conditions than mRNA-loaded ones. Importantly, these novel LNPs showed increased GFP expression that could signify their future use in gene therapies, beyond the established role of LNPs in RNA therapeutics. This article is protected by copyright. All rights reserved.